The PRESEPT Clinical Study Steering Committee (CSSC) advises on study design, oversees study conduct, and will independently analyze and accurately report the interim and final results.

CSSC members:

David Ransohoff, MD, Professor of Medicine, Cancer Epidemiology, Cancer Prevention and Control, University of North Carolina School of Medicine, CSSC Chair

Neal Osborn, MD, Co-Director of Clinical Research, Atlanta Gastroenterology

Timothy Church, PhD, Professor, School of Public Health, University of Minnesota

Brent Blumenstein, PhD, Principal, Trial Architecture Consulting

Dale Snover, MD, Adjunct Professor, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School

Thomas Rösch, MD, Professor, Director of the Clinic for Interdisciplinary Endoscopy, University Hospital Eppendorf, Hamburg, Germany

Robert Day, MD, PhD, President Emeritus of The Fred Hutchinson Cancer Research Center (ex officio member

Michael Wandell, PharmD, Study Director, Epigenomics

Cathy Lofton-Day, PhD, Project Manager, Epigenomics